Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.

Sofi Sennefelt Nyman,Angeliki Dimopoulou Creusen,Ulf Johnsson,Fredrik Rorsman,Johan Vessby,Charlotte Ebeling-Barbier

Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.

2021

Sofi Sennefelt Nyman
Angeliki Dimopoulou Creusen
Ulf Johnsson
Fredrik Rorsman
Johan Vessby
Charlotte Ebeling-Barbier

BackgroundTumor response and survival varies in patients treated with transarterial chemoembolization (TACE) for intermediate stage hepatocellular carcinoma (HCC) and may be associated with several...

Keywords:

Angiography
Medicine
intermediate stage
prognostic factor
in patient
Hepatocellular carcinoma
Radiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations